Novosound claims to have developed the world’s first ultrasonic blood pressure monitor, enabling cuffless blood pressure monitoring in wearable devices with accuracy comparable to conventional electronic cuff devices. The technology is built on the company’s Slanj platform, which also supports hydration tracking, muscle health assessment, and gesture recognition. Novosound previously collaborated at the Texas Medical Center in Houston and plans to showcase its innovations at CES 2025 in Las Vegas. The company is positioning the technology for global wearable and digital health markets. Novosound recently completed a £2 million funding round to accelerate commercialisation. Par Equity and the company cite plans to accelerate internationalisation and global sales. Novosound, founded in 2018 as a spin-out from the University of the West of Scotland, develops flexible ultrasound sensors capable of continuous operation at high temperatures and delivering higher-resolution images. Its sensors are positioned for both medical imaging and industrial non-destructive testing (NDT) to detect below-surface defects, cracks, or corrosion. The company was established by CTO Dave Hughes and CEO Richard Cooper. In December 2019 Novosound raised funding that it will use to match a £1.0m R&D grant from Scottish Enterprise for product development. Management also plans to use the proceeds to pursue expansion into global markets and new industries. The article does not disclose operating metrics such as revenue or user numbers. Novosound develops hi-tech ultrasound sensors for industrial and medical markets, replacing conventional sensor materials with a flexible piezoelectric thin-film. The company is a spin-out from the University of the West of Scotland and is based at the Biocity incubator outside Glasgow. It secured a £1 million grant from Scottish Enterprise to rapidly scale up R&D and accelerate production activity. Novosound will create 17 new STEM roles, bringing staff to more than 30 and plans to establish a dedicated medical sensors team. The firm previously raised £1.5 million in seed funding in April 2018 from early investors including Par Equity, Kelvin Capital, the Scottish Investment Bank and Investing Women. Management says the technology can produce MR-resolution images at lower cost and highlights a large global ultrasonic market opportunity.

Total raised

$8M

Funding rounds

3

Latest round

Equity

Latest activity

Oct 2024